Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Ciudad Madero
Clinical trial register · Mexico

Clinical Trials in Ciudad Madero, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Mexico and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1585 matching records held by the registry are in this view. Synced 09 Oct 2026, 03:18 UTC
1585
Studies in scope
all four open statuses
715
Recruiting now
open to new participants
254
Lead sponsors
across recruiting studies
Top sites
Mexico City 591 Monterrey 374 Guadalajara 348 Chihuahua City 175 Mérida 133
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Eli Lilly and Company13 Novo Nordisk A/S4 Merck Sharp & Dohme LLC2 Bayer2 Hoffmann-La Roche2
Site location
Mexico City591 Monterrey374 Guadalajara348 Chihuahua City175 Mérida133
All 197 locations
Target enrolment
to

Trials with a site in Ciudad Madero

24 of 1585 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Mexico
Start
Not yet open
Eli Lilly and Company
Phase 3
170
Ciudad Madero, Guadalajara, Monterrey
2026-09
Not yet open
Carnot Laboratories
Phase 3
352
Guadalajara, Morelia, Querétaro City, Hermosillo, Ciudad Madero, Mexico City
2026-09
Recruiting
Eli Lilly and Company
Phase 3
2,001
Ciudad Madero, Culiacán, Guadalajara, Mexico City, Mérida, Monterrey, San Nicolás de los Garza, Tlalpan
2026-08-26
Recruiting
Novo Nordisk A/S
Phase 3
1,778
Guadalajara, Tlalpan, Monterrey, Hermosillo, Ciudad Madero, Merida Centro, Mérida
2026-08-24
Recruiting
Bayer
Phase 3
117
Guadalajara, Mexico City, Monterrey, Huixquilucan, Ciudad Madero, Querétaro, San Luis Potosí City, Tlalpan
2026-06-01
Not yet open
Novo Nordisk A/S
Phase 3
1,000
Guadalajara, Monterrey, Ciudad Madero
2026-05-20
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Col Saucito, Guadalajara, México, Delegacion Cuauhtemoc, Cuernavaca, San Pedro Garza García, Ciudad Madero
2026-03-23
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Col Saucito, Guadalajara, Delegacion Cuauhtemoc, México, Cuernavaca, San Pedro Garza García, Ciudad Madero
2026-03-16
Recruiting
Eli Lilly and Company
Phase 3
7,140
Actopan, Ciudad Madero, Cuernavaca, Culiacán, Durango, Guadalajara, Hermosillo, León
2025-12-01
Recruiting
Bayer
Phase 3
111
Guadalajara, Mexico City, Monterrey, Huixquilucan, Ciudad Madero, Querétaro, San Luis Potosí City, Tlalpan
2025-11-19
Recruiting
Eli Lilly and Company
Phase 3
1,000
Chihuahua City, Ciudad Madero, Juriquilla, Mexico City, Mérida, México, Monterrey, Morelia
2025-09-30
Active, closed
Eli Lilly and Company
Phase 3
800
Chihuahua City, Ciudad Madero, Mexicali, Mérida, Monterrey
2025-09-15
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Actopan, Aguascalientes, Ciudad Madero, Cuernavaca, Culiacán, Guadalajara, Hermosillo, León
2025-09-02
Recruiting
Eli Lilly and Company
Phase 3
290
Aguascalientes, Chihuahua City, Ciudad Madero, Durango, Guadajalara, Guadalajara, Juriquilla, Mexico City
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
350
Aguascalientes, Chihuahua City, Ciudad Madero, Durango, Guadajalara, Guadalajara, Juriquilla, Mexico City
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
55
Ciudad Madero, Puebla City, Tampico, Tlalpan, Veracruz
2025-01-10
Active, closed
Novo Nordisk A/S
Phase 4
500
Monterrey, Ciudad Madero, Puebla City
2024-09-17
Active, closed
Eli Lilly and Company
Phase 3
10,000
Actopan, Aguascalientes, Ciudad Madero, Cuauhtémoc, Ciudad de México, Cuernavaca, Durango, Guadalajara, León
2024-04-30
Active, closed
Eli Lilly and Company
Phase 2
414
Tijuana, Guadalajara, Cuauhtémoc, Ciudad de México, Mexico City, Monterrey, Ciudad Madero
2023-09-21
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
342
León, Guadalajara, Mexico City, Monterrey, Hacienda de Las Palmas, Ciudad Madero, Aguascalientes, Colima
2023-05-31
Active, closed
Novo Nordisk A/S
Phase 3
7,101
Guadalajara, Cuernavaca, Monterrey, San Luis Potosí City, Culiacán, Ciudad Madero, Xalapa, Aguascalientes
2023-03-01
Active, closed
Eli Lilly and Company
Phase 3
15,374
Aguascalientes, Chihuahua City, Ciudad Madero, Cuauhtémoc, Cuernavaca, Culiacán, Durango, Guadalajara
2022-10-11
Active, closed
Eli Lilly and Company
Phase 3
8,000
Chihuahua City, Ciudad Madero, Guadalajara, León, Mexico City, Monterrey, Oaxaca City, Puebla City
2022-10-04
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
La Paz, Guadalajara, Mexico City, Monterrey, San Pedro Garza García, Oaxaca City, Ciudad Madero, Mérida
2018-08-21
Rows per page Showing 1–24 of 24
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Mexican investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-mexico/city/ciudad-madero

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Mexico and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,585 studies in total at the last sync on 09 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 24 of those studies with a site in Ciudad Madero.

How many clinical trials are recruiting in Ciudad Madero?

14 of the 24 studies on this page are recruiting new participants as of the 09 Oct 2026, 03:18 UTC sync. A further 3 have not yet opened recruitment, 7 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ciudad Madero), 24 studies
PhaseStudiesRecruitingShare
Phase 3211387.5%
Phase 2104.2%
Phase 2/3114.2%
Phase 4104.2%

Most active sponsors

Lead sponsors with the most studies (Ciudad Madero)
Lead sponsorStudiesRecruiting
Eli Lilly and Company137
Novo Nordisk A/S41
Bayer22
Hoffmann-La Roche22
Merck Sharp & Dohme LLC22
Carnot Laboratories10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.